17 December 2020 in PLOS Genetics
The Betacoronaviruses comprise multiple subgenera whose members have been implicated in human disease. As with SARS, MERS and now SARS-CoV-2, the origin and emergence of new variants are often attributed to events of recombination that alter host tropism or disease severity. In most cases, recombination has been detected by searches for excessively similar genomic regions in divergent strains; however, such analyses are complicated by the high mutation rates of RNA viruses, which can produce sequence similarities in distant strains by convergent mutations. By applying a genome-wide approach that examines the source of individual polymorphisms and that can be tested against null models in which recombination is absent and homoplasies can arise only by convergent mutations, we examine the extent and limits of recombination in Betacoronaviruses. We find that recombination accounts for nearly 40% of the polymorphisms circulating in populations and that gene exchange occurs almost exclusively among strains belonging to the same subgenus. Although experimental studies have shown that recombinational exchanges occur at random along the coronaviral genome, in nature, they are vastly overrepresented in regions controlling viral interaction with host cells.
8 April 2021 in Journal of General Virology
Mosquito-borne arboviruses, including a diverse array of alphaviruses and flaviviruses, lead to hundreds of millions of human infections each year. Current methods for species-level classification of arboviruses adhere to guidelines prescribed by the International Committee on Taxonomy of Viruses (ICTV), and generally apply a polyphasic approach that might include information about viral vectors, hosts, geographical distribution, antigenicity, levels of DNA similarity, disease association and/or ecological characteristics. However, there is substantial variation in the criteria used to define viral species, which can lead to the establishment of artificial boundaries between species and inconsistencies when inferring their relatedness, variation and evolutionary history. In this study, we apply a single, uniform principle – that underlying the Biological Species Concept (BSC) – to define biological species of arboviruses based on recombination between genomes. Given that few recombination events have been documented in arboviruses, we investigate the incidence of recombination within and among major arboviral groups using an approach based on the ratio of homoplastic sites (recombinant alleles) to non-homoplastic sites (vertically transmitted alleles). This approach supports many ICTV-designations but also recognizes several cases in which a named species comprises multiple biological species. These findings demonstrate that this metric may be applied to all lifeforms, including viruses, and lead to more consistent and accurate delineation of viral species.
3 September 2025 in Proceedings of the National Academy of Sciences
Nanobodies have been pursued as candidates for antimicrobial design due to their small size and versatile binding capacities, but direct antibacterial activity of a nanobody has yet to be described. Here, we employed a bacterial surface display platform to screen a synthetic library of nanobody variants for antimicrobial potential. We identified a candidate that binds the essential lipid A component of gram-negative lipopolysaccharide. Nonetheless, this nanobody required a weakened outer membrane to access its target and elicit its toxic activity. Borrowing from observations of innate immune proteins, we found that resurfacing nanobodies with positively charged residues enabled them to bind and perturb the gram-negative outer membrane, but this alone was not sufficient for toxic activity. However, when we resurface our lipid A-targeting nanobody, it gained the ability to disrupt the outer membrane and enact its antibacterial function against wild-type bacteria. This development of a dual-function nanobody that can reach and bind previously inaccessible gram-negative targets introduces a route for antimicrobial biologic advancement.
22 April 2026 in Applied and Environmental Microbiology
Serratia marcescens is a highly environmentally adaptable gram-negative bacterium which can be found in both free-living and host-associated lifestyles, where it can function as either a commensal or a pathogen. The diverse array of secreted factors produced by S. marcescens is suggested to facilitate this adaptability. Here, we describe and validate a class of secreted bacteriocins, called class II microcins, which have not previously been described in S. marcescens . Putative class II microcins are found in the majority (96%) of genomes analyzed here, including representative strains from numerous diverse lifestyles. The type of microcin in a given genome has some correspondence to the isolation source of its S. marcescens strain of origin. We demonstrate that heterologous secretion of these microcins can be used to validate their antibacterial activity, yielding 17 confirmed class II microcins from S. marcescens . Testing against a panel of S. marcescens , consisting predominantly of strains pathogenic to humans or insects, shows S. marcescens microcin activity ranges from narrow to broad spectrum. Identifying class II microcins and other factors which may contribute to interbacterial competition or colonization by S. marcescens could inform strategies to prevent S. marcescens infections. IMPORTANCE: Serratia marcescens is an abundant bacterium in many different environments, but it also represents an important opportunistic pathogen of humans and other animals. Our finding that S. marcescens encodes numerous antibacterial class II microcins is important to understanding factors that may contribute to the lifestyle versatility of this bacterium. Interfering with factors that promote competition or colonization could aid infection prevention.